ImmuneAGE Bio

Private

LausanneHealthcare & Life Scienceshttps://immuneage.bio

Last Round

Seed

Jul 12, 2024

Total Funding Raised

$2.05M

Company Overview

ImmuneAGE Bio is a biotechnology company that provides a drug discovery platform focused on rejuvenating the immune system by targeting hematopoietic stem cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

hematopoietic stem cellsHSCimmune rejuvenationlongevity biotechdrug discovery platformex vivo expansionsmall-molecule therapeuticsbone marrow transplantationanti-aging therapycell therapyinvestigational new drugINDregenerative medicinechemotherapy recovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImmuneAGE Bio Comps

Public and private peers based on sector, stage, and business model.

ImmuneAGE Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ImmuneAGE Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 12, 2024
Pre Seed	May 10, 2023

View all Funding Rounds

ImmuneAGE Bio Investors

Notable investors and investment history

ImmuneAGE Bio investors
Investor	Rounds
1517 Fund	Seed
VitaDAO	Pre Seed, Seed
Infinita Fund	Seed
Healthspan Capital	Seed

View all Investors

ImmuneAGE Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ImmuneAGE Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImmuneAGE Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne

Employee Range1

Year Founded2022

Last FundingJul 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.